Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 5649-5651, November 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adesina, A. M.
Right arrow Articles by Cavenee, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adesina, A. M.
Right arrow Articles by Cavenee, W. K.

p53 Gene Mutation and mdm2 Gene Amplification Are Uncommon in Medulloblastoma1

Adekunle M. Adesina2, Josephine Nalbantoglu and Webster K. Cavenee

Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada [A. M. A., J. N.], and Department of Medicine and Center for Molecular Genetics, Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, California 92093-0660 [W. K. C.]

Loss of heterozygosity is common for the short arm of chromosome 17 in medulloblastomas, and putative medulloblastoma suppressor loci have been localized to 17p13. The colocalization of the p53 tumor suppressor gene to 17p13 raises the possibility that its mutant alleles may play a role in the malignant transformation of "medulloblasts." Mutations and deletions of the p53 gene have been described in many tumor types and in the germline of some individuals with the Li-Fraumeni syndrome, but reports on the status of the p53 and mdm2 (a gene coding for a p53-associated protein reportedly amplified in human sarcomas) genes in medulloblastomas are few and an indication of their roles, if any, in the etiology of this important childhood tumor has yet to emerge. Here we have analyzed polymerase chain reaction-amplified products of exons 4–9 (95% of reported p53 mutations occur within this region) of the p53 gene in 9 medulloblastomas for potential mutations using the technique of single strand conformation polymorphism analysis and DNA sequencing. We found only one mutation, an A-T to T-A transversion involving the second base of codon 285 and resulting in the substitution of valine for glutamic acid. amplification of the mdm2 gene could be detected in zero of eight of these tumors. These findings suggest that genetic events associated with the inactivation of p53 gene occur in only a minor subset of medulloblastomas.

1 This work was funded in part by an establishment grant from Fonds de la recherche sante du Quebec (J. N.). J. N. is a Chercheur Boursier of Fonds de la recherche sante du Quebec.

2 To whom requests for reprints should be addressed, at Department of Pathology, University of Oklahoma Health Sciences Center, P.O. Box 26901, Oklahoma City, OK 73190.

Received 3/28/94. Accepted 8/25/94.




This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Neuro-oncol, January 1, 2008; 10(6): 1040 - 1060.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. Mendrzyk, B. Radlwimmer, S. Joos, F. Kokocinski, A. Benner, D. E. Stange, K. Neben, H. Fiegler, N. P. Carter, G. Reifenberger, et al.
Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma
J. Clin. Oncol., December 1, 2005; 23(34): 8853 - 8862.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Lee, H. L. Miller, P. Jensen, R. Hernan, M. Connelly, C. Wetmore, F. Zindy, M. F. Roussel, T. Curran, R. J. Gilbertson, et al.
A Molecular Fingerprint for Medulloblastoma
Cancer Res., September 1, 2003; 63(17): 5428 - 5437.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Q. Yang, D. Senger, H. Muzik, Z. Q. Shi, D. Johnson, P. M. A. Brasher, N. B. Rewcastle, M. Hamilton, J. Rutka, J. Wolff, et al.
Reovirus Prolongs Survival and Reduces the Frequency of Spinal and Leptomeningeal Metastases from Medulloblastoma
Cancer Res., June 15, 2003; 63(12): 3162 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. G. Eberhart
Medulloblastoma in Mice Lacking p53 and PARP: All Roads Lead To Gli
Am. J. Pathol., January 1, 2003; 162(1): 7 - 10.
[Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
M. T. Giordana, D. Duo, S. Gasverde, E. Trevisan, A. Boghi, I. Morra, L. Pradotto, A. Mauro, and A. Chio
MDM2 overexpression is associated with short survival in adults with medulloblastoma
Neuro-oncol, April 1, 2002; 4(2): 115 - 122.
[Abstract] [PDF]


Home page
Mol. Pathol.Home page
L Del Valle, J Baehring, C Lorenzana, A Giordano, K Khalili, and S Croul
Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas
Mol. Pathol., October 1, 2001; 54(5): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Huang, B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues, and H. Ohgaki
APC Mutations in Sporadic Medulloblastomas
Am. J. Pathol., February 1, 2000; 156(2): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Krynska, L. Del Valle, S. Croul, J. Gordon, C. D. Katsetos, M. Carbone, A. Giordano, and K. Khalili
Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas
PNAS, September 28, 1999; 96(20): 11519 - 11524.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. M. Adesma
Topical Review: Molecular Heterogeneity in Medulloblastoma With Implications for Differing Tumor Biology
J Child Neurol, July 1, 1999; 14(7): 411 - 417.
[Abstract] [PDF]


Home page
Neuro Oncol DukeHome page
M. Nozaki, M. Tada, H. Kobayashi, C.-L. Zhang, Y. Sawamura, H. Abe, N. Ishii, and E. G. Van Meir
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Neuro-oncol, April 1, 1999; 1(2): 124 - 137.
[Abstract] [PDF]


Home page
Cell Growth Differ.Home page
J. A. Meyerhardt, K. Caca, B. C. Eckstrand, G. Hu, C. Lengauer, S. Banavali, A. T. Look, and E. R. Fearon
Netrin-1: Interaction with Deleted in Colorectal Cancer (DCC) and Alterations in Brain Tumors and Neuroblastomas
Cell Growth Differ., January 1, 1999; 10(1): 35 - 42.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
H.-K. G. Shu, M. M. Kim, P. Chen, F. Furman, C. M. Julin, and M. A. Israel
The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21BAX expression
PNAS, November 24, 1998; 95(24): 14453 - 14458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.